Loring Wolcott & Coolidge Fiduciary Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Buy |
|
|||||
|
2025
Q1 | $342K | Hold |
|
|||||
|
2024
Q4 | $308K | Buy |
|
|||||
|
2024
Q3 | $311K | Buy |
|
|||||
|
2024
Q2 | $273K | Hold |
|
|||||
|
2024
Q1 | $224K | Buy |
|
|||||
|
2023
Q4 | $237K | Hold |
|
|||||
|
2023
Q3 | $206K | Hold |
|
|||||
|
2023
Q2 | $192K | Buy |
|
|||||
|
2023
Q1 | $170K | Buy |
|
|||||
|
2022
Q4 | $114K | Hold |
|
|||||
|
2022
Q3 | $114K | Hold |
|
|||||
|
2022
Q2 | $111K | Buy |
|
|||||
|
2022
Q1 | $80K | Hold |
|
|||||
|
2021
Q4 | $67K | Sell |
|
|||||
|
2021
Q3 | $57K | Sell |
|
|||||
|
2021
Q2 | $69K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $180K | Sell |
|
|||||
|
2020
Q3 | $254K | Hold |
|
|||||
|
2020
Q2 | $271K | Buy |
|
|||||
|
2020
Q1 | $163K | Sell |
|
|||||
|
2019
Q4 | $185K | Hold |
|
|||||
|
2019
Q3 | $143K | Buy |
|
|||||
|
2019
Q2 | $138K | Hold |
|
|||||
|
2019
Q1 | $139K | Hold |
|
|||||
|
2018
Q4 | $125K | Hold |
|
|||||
|
2018
Q3 | $146K | Hold |
|
|||||
|
2018
Q2 | $128K | Sell |
|
|||||
|
2018
Q1 | $134K | Hold |
|
|||||
|
2017
Q4 | $123K | Buy |
|
|||||
|
2017
Q3 | $95K | Hold |
|
|||||
|
2017
Q2 | $95K | Sell |
|
|||||
|
2017
Q1 | $87K | Hold |
|
|||||
|
2016
Q4 | $59K | Hold |
|
|||||
|
2016
Q3 | $70K | Hold |
|
|||||
|
2016
Q2 | $69K | Hold |
|
|||||
|
2016
Q1 | $64K | Hold |
|
|||||
|
2015
Q4 | $101K | Hold |
|
|||||
|
2015
Q3 | $99K | Hold |
|
|||||
|
2015
Q2 | $99K | Hold |
|
|||||
|
2015
Q1 | $94K | Sell |
|
|||||
|
2014
Q4 | $154K | Hold |
|
|||||
|
2014
Q3 | $146K | Hold |
|
|||||
|
2014
Q2 | $123K | Hold |
|
|||||
|
2014
Q1 | $92K | Sell |
|
|||||
|
2013
Q4 | $110K | Buy |
|
|||||
|
2013
Q3 | $23K | Hold |
|
|||||
|
2013
Q2 | $24K | Buy |
|